Overview - COCP US

Cocrystal Pharma Inc

COCP.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. The company is headquartered in Bothell, Washington.

symbol	last	change	%chng	name	mcap	sector	wiki
COCP				Cocrystal Pharma Inc	0.015B	Healthcare

	symbol	prev.close	range	chart	target	percent	period	months	due	rating
D	COCP	1.56	0,-1.497,-0.577,0.099,-1.497	1.60,1.55,1.61,1.52,1.56,1.46,1.46,1.50,1.48,1.49,1.47,1.50,1.54,1.46,1.54	1.23-1.80	-2.76%	267,114,267	5.1	Jan 5-Sep 28	42.34%

Intraday chart for COCP

Please reload the page if latest figures not showing

Key financials

The following extracted figures are selected by the AI as the most essential for predicting future price movements. The arrows show the how the AI thinks the figure affects the stock price (not the change in the figure)

. operatingIncome	-6M
. . netInterestIncome	0M
. incomeBeforeTax	-4M
. otherOperatingExpenses	6M
. netIncomeApplicableToCommonShares

. reconciledDepreciation	-2M
. netWorkingCapital	26M
. netInvestedCapital	26M
. netDebt	-25M
. totalCashFromOperatingActivities	-3M
. freeCashFlow. .	-3M

News for COCP

headline news | recent news | latest news | market news

Chart COCP

Similar stocks g.varicella

Castlight Health Inc	CSLT	US	Healthcare	10.7994	335M	-
China Distance Education Holdings Limited	DL	US	Consumer Defensive	11.8613	333M	-
Kamada	KMDA	US	Healthcare	22.1823	325M	-
Mediwound Ltd	MDWD	US	Healthcare	12.574	156M	-
Cheetah Mobile Inc	CMCM	US	Communication Services	12.6814	139M	-
Sesen Bio Inc	SESN	US	Healthcare	12.0179	118M	-
LightInTheBox Holding Co Ltd ARD	LITB	US	Consumer Cyclical	11.2307	92M	-
ClearSign Combustion Corporation	CLIR	US	Industrials	12.6636	38M	-
Acasti Pharma Inc	ACST	US	Healthcare	11.3364	32M	-
Renren Inc	RENN	US	Technology	11.5927	31M	-

Myshare aims to provide good clear honest and easy analysis of financial markets using a scientific, teaching and informative approach. We try hard but please read our disclaimer. Pages are provided by ourselves and our users. Register to edit pages and see the documentation

Global news | headline news | recent news | latest news | market news | topics | stock topics

News topics and stories from around the world and in the selected country

US News | headline news | recent news | latest news | market news | recent topics | stock topics

News from major news outlets like BBC, CNN and Reuters

Forecasts | Forecast buy | Forecast sell | Forecast up | Forecast down | Forecast sector

Long term stock predictions using AI reading the financial accounts of each company.

``` ``` ``` ```